ask="34.00"
ask_size="300"
average_daily_volume="220495"
bid="20.15"
bid_size="100"
book_value="3.79"
change="+0.52"
change_from_200_day_moving_average="7.06"
change_from_50_day_moving_average="4.83"
change_from_52_week_high="-0.08"
change_From_52_week_low="18.53"
change_in_percent="+1.62%"
close="32.65"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-2.97"
ex_dividend_date="N/A"
float_shares="15631000"
high="32.73"
high_52_weeks="32.73"
last_trade_date="3/6/2017"
last_trade_price="32.65"
last_trade_size="5606"
last_trade_time="4:00pm"
low="31.30"
low_52_weeks="14.12"
market_capitalization="699.75M"
moving_average_200_day="25.59"
moving_average_50_day="27.82"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="32.13"
pe_ratio="N/A"
peg_ratio="-0.22"
percent_change_from_200_day_moving_average="+27.60%"
percent_change_from_50_day_moving_average="+17.35%"
percent_change_from_52_week_high="-0.24%"
percent_change_from_52_week_low="+131.23%"
previous_close="32.13"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.48"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="7.75"
stock_exchange="NMS"
symbol="ACRS"
volume="174044"
weeks_range_52="14.12 - 32.73"
